Loading
Sabra Health Care REIT, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Cusack Catherine, was filed 25 Feb 2025.
Insider Decl.
800
Thresholds
n/a
Buy Volume
€310,053
9 ops. · all time
Sell Volume
€10M
14 ops. · all time
Who traded when
BuySaleCatherine Cusack2 buys
Jessica Flores1 sale
Michael J. Foster1 sale
Richard K. Matros1 sale
Since the insiders bought
- +27.3%Entry US$16.39 · Close at T+365 US$20.86
- +38.1%Entry US$12.63 · Close at T+365 US$17.44
- +206.2%Entry US$5.92 · Close at T+365 US$18.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Sabra Health Care REIT, Inc. Buy (bullish), based on 14 analysts. Average price target: US$22.36.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$18.90
Analyst consensus
14 analystsBuy
US$19.00Target US$22.36(+18%)US$25.00
Income statement
RevenueUS$774.6M
Gross profitUS$503.5M65% margin
EBITDAUS$456.8M59% margin
Net incomeUS$155.6M7.6% margin
Valuation
PER (trailing)75.6x
PER (forward)23.3x
P/Book1.8x
Beta0.62
Balance sheet & cash
Market capUS$4.8B
Total debtUS$2.6B
Free Cash FlowUS$348.6M
Debt / Equity96%
Profitability & ownership
ROE2.4%
ROA1.9%
% insiders1.4%
% institutions105.3%
Last declaration on 9 September 2026
Declarations800 total
200,000 shares@ US$20.830.083% mcap18.2% of flowCommon StockSEC:0001184158-26-000016:0
200,000 shares@ US$20.750.082% mcap100.0% of flowCommonSEC144:0001628280-26-060841
8,310 sharesCommon StockSEC:0001472457-26-000008:0
8,310 sharesCommon StockSEC:0001838868-26-000008:0
8,310 sharesCommon StockSEC:0001145246-26-000012:0
4,200 shares0Common StockSEC:0001838630-26-000010:0
817 shares0Common StockSEC:0001472457-26-000004:0
490 shares0Common StockSEC:0001145246-26-000006:0
813 shares0Common StockSEC:0001145246-26-000004:0
15,231 shares@ US$19.86100.0% of flowCommon StockSEC:0002003768-26-000012:0
368 shares0Common StockSEC:0002003768-26-000009:0
781 shares0Common StockSEC:0001838868-26-000002:0
781 shares0Common StockSEC:0001837209-26-000002:0
781 shares0Common StockSEC:0001472457-26-000002:0
478 shares0Common StockSEC:0002104848-26-000008:0
4,005 shares0Common StockSEC:0001838630-26-000008:0
781 shares0Common StockSEC:0001770419-26-000002:0
781 shares0Common StockSEC:0001650988-26-000002:0
13,358 shares0Common StockSEC:0001184158-26-000008:0
781 shares0Common StockSEC:0001145246-26-000002:0
14,088 shares0Common StockSEC:0002104848-26-000006:2
1,172 shares@ US$19.153.3% of flowCommon StockSEC:0002003768-26-000007:1
2,927 shares@ US$19.1514.5% of flowCommon StockSEC:0002104848-26-000006:1
6,390 shares@ US$19.1531.7% of flowCommon StockSEC:0002104848-26-000006:3
3,198 shares0Common StockSEC:0002003768-26-000007:0
25 of 800 declarations
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT is an equity-pay record: 718 grants out of 800 filings, no option exercises, 59 filings of another kind and few market trades: 14 sales worth EUR 9.7 million (median EUR 175,145) and 9 purchases worth EUR 310,053 (median EUR 22,798), so 39% are purchases.
Richard K. Matros (Chair, CEO and President) sold EUR 3,581,094 on September 8, 2026 and EUR 2,433,737 on November 4, 2019; Harold W. Andrews Jr. (Executive VP, CFO & Secretary) sold EUR 1,317,518 on December 29, 2021. The largest purchases are by Catherine Cusack (Director), EUR 93,310 on May 22, 2024 and EUR 28,467 on May 13, 2021, and by Michael J. Foster (Director), EUR 66,869 on March 16, 2020.
Read moreShow less
Richard K. Matros is the top filer, with 140 filings, ahead of Talya Nevo-Hacohen (Executive VP, CIO & Treasurer, 91), Craig A. Barbarosh (Director, 70), Michael J. Foster (69) and Harold W. Andrews Jr. (64). Annual volume runs from 43 in 2026 to 95 in 2021. Filings come out a median of 4 days after the trade. In the last twelve months, 53 filings, 2 of them sales. 18 filers, 1.4% of the capital held by insiders, a Nasdaq real estate company worth USD 4.9 billion.
